Porownywarka
Cosyntropin vs Oxytocin side-by-side
Zestaw do czterech peptydów według statusu dowodów, mechanizmów, dawkowania z badań, skutków ubocznych i referencji.
Porownywarka
Zestaw do czterech peptydów według statusu dowodów, mechanizmów, dawkowania z badań, skutków ubocznych i referencji.
Wybrane (2/4)
Udostępnij porównanie peptydów
| Wlasciwosc | Cosyntropin | Oxytocin |
|---|---|---|
| Kategoria | Hormonalne | Hormonalne |
| Znany tez jako | Cortrosyn, ACTH 1-24, Tetracosactide | Pitocin, Syntocinon, The Love Hormone |
| Zatwierdzony przez FDA | Tak | Tak |
| Status kliniczny | FDA Approved - Diagnostic use
| FDA approved for labor and postpartum use; other uses remain under research
|
| Czego oczekiwac | Adrenal function testing, diagnostic use | Social bonding, anxiety, trust, emotional wellbeing |
| Jak dziala | Cosyntropin is the 1-24 amino-acid portion of ACTH, while endogenous ACTH is described as 39 amino acids long. The source reports that this fragment activates the melanocortin-2 receptor on adrenal cortex cells, which can produce a rapid cortisol rise; the diagnostic value comes from observing whether the adrenal response occurs as expected. | Oxytocin acts through the oxytocin receptor, a G-protein-coupled receptor described in the source as present in the uterus, breast tissue, and multiple brain areas including the amygdala. In peripheral tissues, signaling is linked to calcium-mediated uterine contraction and milk ejection. Central effects are described as modulation of fear, reward, and social-attention circuitry, but intranasal research is difficult to interpret because the amount reaching the brain is uncertain and may involve indirect pathways. |
| Typowe dawkowanie | Limited community data available · See research protocols | 10-24 IU intranasal as needed · As needed · Intranasal |
| Dawkowanie z badań | 250 mcg IV/IM (standard) · Single diagnostic dose · IV or intramuscular | 10-40 IU IV for labor · Single dose or short-term use · IV (obstetric); intranasal (research) |
| Typowy czas trwania | Single diagnostic dose | Single dose or short-term use |
| Podanie | IV or intramuscular | IV in obstetric labeling; intranasal in research contexts |
| Timing | Morning or as directed With or without food | As needed in studied social or bonding contexts With or without food |
| Poziom dowodów | Zatwierdzone przez FDA | Zatwierdzone przez FDA |
| Mozliwe skutki uboczne |
+4 więcej
|
+4 więcej
|
| Podsumowanie researchu | The source characterizes cosyntropin as an FDA-approved, clinically established diagnostic agent. It reports a standard adult diagnostic dose of 250 micrograms, also expressed as 0.25 mg, administered IV or intramuscularly. The described testing approach measures serum cortisol before dosing and again at 30 and 60 minutes. A response reaching roughly 18 micrograms per deciliter is described as generally normal, while assay choice can shift thresholds, including lower cutoffs with LC-MS/MS. A weak cortisol rise may support adrenal insufficiency assessment, with the source distinguishing primary adrenal disease from possible secondary or tertiary causes and noting interpretation caveats. The evidence focus is diagnostic accuracy and test interpretation, not therapeutic benefit. | The source treats injectable obstetric oxytocin as established, while describing intranasal behavioral research as contested. For social reward, a 2023 systematic review covering 19 randomized, double-blind, placebo-controlled studies and about 984 participants reported a clearer signal in brain-activity outcomes than in behavior or self-report. In autism research, the source cites a 2021 Scientific Reports randomized trial that did not find a substantial empathy-related neural activation change, and it notes that repeated-dose studies have ranged from modest social-behavior findings to no clear effect. Context and sex-specific differences are presented as important reasons the findings remain difficult to generalize. Short-term intranasal trial safety was described as reassuring, but the source does not establish a reliable clinical benefit for these investigational uses. |
| Referencje | ||
| Pełny profil | Zobacz szczegóły | Zobacz szczegóły |
Zapisz to porównanie
Trzymaj ten zestaw researchowy pod reka na darmowym koncie PeptiGuide.
Zapisz porównanie - darmowe kontoTrackuj swoja ścieżkę peptydówa
Zamien research w prywatny log protokołu, gdy będziesz gotowy.
Trackuj ścieżkę peptydówaWyłącznie edukacyjnie. Te informacje są agregowane z publicznych badań i raportów społeczności. To nie jest poradą medyczną, a informacje o dawkowaniu są opisowe, nie rekomendacyjne. Zawsze konsultuj się z wykwalifikowanym specjalistą ochrony zdrowia.